Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation

Cited by (122)

Items 101–122 of 122

1. An in Silico Approach to Study Tauopathies in Alzheimer's Disease and Modeling of Neuroprotective Compounds Targeting Neurofibrillary Tangles
   Vankudavath Rajunaik, Harikrishnan Narayanan Unni, Shyam Perugu, B Preethi, Devraj J. Parasannanavar · 2025 · IEEE International Conference on Bioinformatics and Bioengineering (BIBE)
2. Investigating the synergistic effects of herbal plants in addressing Parkinson’s disease
   Sachchida Nand, Payal Singh, Falguni Goel · 2025 · Elsevier eBooks
3. Mechanistic Pathways of Bioactive Phytocompounds in Neurodegenerative Disorders
   Jhanvi Soni, Neeraj Kumar · 2026 · Springer eBooks
4. Curcuma longa-Derived Curcumin Nanoparticles in Experimental Models of Alzheimer’s Disease: A Formulation-Based Approach
   Pasrija Kanika, Alka Patel, Bichitrananda Tripathy · 2026 · Probecell Science
5. Network pharmacology and computational insights into the therapeutic potential of natural inositol from Madhuca longifolia as a safer alternative to synthetic Methylinositol targeting GSK-3β in Alzheimer's disease
   Noopur Khare, Atul Kumar, Tanvi Jain, Sachidanand Singh · 2026 · Next research.
6. Phytochemical Screening and In Vitro Antioxidant Analysis of Colebrookea oppositifolia Sm. Extract
   Rohit Malik, Santosh Kumar Singh, Prashant Kumar · 2026 · International Electronic Conference on Applied Sciences (ASEC)
7. In Silico Screening of Phytochemicals Against Epilepsy and Other Neural Disorders
   Naglaa S. Ashmawy, Marwa Mahmoud Mady, Alya Ali Arasteh, Ruqaiya Sahrish, Danya Labash, Nikita Sunil Binu, Sumaiya Mohsin, Ahmed T. Negmeldin, Mohamed El-Shazly · 2026 · Advances in Science, Technology & Innovation/Advances in science, technology & innovation
8. Serum Expression of miR-106b-3p and Its Diagnostic Significance in Alzheimer Disease
   Dan Hou, Zhiyong Hou, Hong Qu, Ming Yang Sun, Liping Wang · 2026 · Alzheimer Disease & Associated Disorders
9. Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges
   Andreas Wilson Setiawan, J T Choi, Sohyun Park, Min Choi, Raymond R. Tjandrawinata, Edwin Hadinata, Moon Nyeo Park, Taruna Ikrar, Fahrul Nurkolis, Bonglee Kim · 2026 · Pharmaceuticals
10. “Behavioral and Neuroinflammatory Evaluation of a Novel Isoxazole-5-One Derivative in Animal Models of Alzheimer’s Disease via TNF-α, COX-2, IL-6, and NF-κB Modulation”
    Nitasha Gohar, Muzaffar Abbas, Syed Muzzammil Masaud, Iqra Zulfiqar, Hafsa Jabeen, Nadia Shamshad Malik, Humaira Nadeem · 2026 · ACS Omega
11. An Overview of Dementia and Alzheimer's
    Rahul Trivedi, Rajesh A. Maheshwari, Kinjal Prahaladbhai Patel, Shweta Bhandari, Rajesh Hadia, Swapnil Goyal, Rupesh Soni · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
12. In silico characterization of Desmodium gangeticum compounds as dual modulators of MAO-B and 5-HT2A in Parkinson’s disease: an integrated approach combining molecular docking, ADMET profiling, MM-GBSA, QSAR modeling, and molecular dynamics simulation
    Oluwabusayo Esther Akinma, O. S. Akinola, Ifeoluwa Deborah OJO, Akinyode Isaac Olopoda, Ifedayo David Akerele, Bright Bayonle Akinyemi, Folashade Ayodeji, Olusola Olalekan Elekofehinti · 2026 · In Silico Pharmacology
13. Pharmacometabolomic study of butanol and ethyl acetate fractions of Pulmonaria officinalis L. revealing neuroprotective effects in LPS-induced alzheimer’s
    Abeer Salama, Mona A. Mohammed, Rasha M.M. Mohasib · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
14. Role of Tinospora cordifolia (Willd.) Hook. F. in neurological disorders: A comprehensive review and network pharmacology-based analysis
    Ruchi Sharma, Subhadip Banerjee, Richa Arya, Vinod K. Tiwari, Pradeep Kumar Prajapati, Kow‐Tong Chen, Rohit Sharma · 2026 · Journal of Pharmacological Sciences
15. Majoon-e-Boolis as a neurotherapeutic agent: cognitive and neuronal restoration in alzheimer’s disease model
    Owais Hassan Wani, Prashant Dhaka, Pinky, Shahid Shah Chaudhary, Asrar Ahmad Wani, Arsheed Iqbal, Suhel Parvez, Tanveer Ali Dar · 2026 · Metabolic Brain Disease
16. Nanoconjugated caffeic acid-gold nanoparticles for passive diffusion of simulated blood-brain barrier and neuroprotective activity
    Sara Nistor, Mihaela Beregoi, Alexandru Evanghelidis · 2026 · Materials & Design
17. Advances in phytochemical modulation of protein aggregation in neurodegenerative diseases
    Nitu Kumari, Santosh Anand · 2026 · 3 Biotech
18. Phytotherapeutic targeting of mitochondria in Alzheimer’s disease: A narrative review
    Ibe Michael USMAN, Ismahil Adekunle Adeniyi, Caroline Asekenye, Okechukwu Paul-Chima Ugwu, David Chibuike Ikwuka, Hussen Abdu Muhidin, Catherine Chukumuaya Wali, Mario Edgar Fernandez Diaz, VB Archibong · 2026 · Phytomedicine Plus
19. Virtual screening of phytochemicals against multiple protein targets of Alzheimer’s disease
    Samuel Mesfin, Naamah Bloch, Abraham O. Samson · 2026 · Frontiers in Drug Discovery
20. Health benefits and physiological actions of micronutrients, probiotics/prebiotics, phytochemicals, and their associated deficiency diseases: a systematic review of recent developments and applications
    Chinaza Godswill Awuchi, Ayomide Victor Atoki, Chinelo Kate Echeta · 2026 · Cogent Food & Agriculture
21. Transcriptomics-guided mechanistic mapping of phytotherapeutics for alzheimer’s disease
    Thoshitha Veerasamy, Nandhini Sundaresan · 2026 · Pharmacological Research - Modern Chinese Medicine
22. Plant-derived phytochemicals for Alzheimer’s disease: mechanisms of action, experimental evidence, and therapeutic perspectives
    Janhavi Nimbalkar, Rushikesh Shinde · 2026 · Journal of Natural Medicines